Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Riccardo Fontana und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Biotechnology, School of Pharmacy and Heath Products, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Magnolia, Lignans, Respiratory Tract Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bologna, University of Ferrara, Università di Bologna.
Abstract (Originalsprache)
The understanding of the use of Magnolia officinalis L. (Magnoliaceae) as a possible dietary supplement for supporting the treatment of airway pathologies might be of clinical interest. Two commercially available bark extracts ( M . officinalis extract [MOE]) were characterized by quantitation in honokiol and magnolol content by means of high‐performance liquid chromatography with UV detection. MOE effects, as well as those of the reference compounds per se, on some targets connected to airway pathologies (antibacterial‐ and lung and trachea relaxing‐ activities) were investigated. Results showed that MOE possessed interesting antibacterial activity against Staphylococcus aureus , Pseudomonas aeruginosa , and Streptococcus pneumoniae . This was accompanied by a spasmolytic and antispasmodic activity, possibly owing to its ability to concurrently modulate different targets such as H 1 ‐, β 2 ‐ and muscarinic receptors and l ‐type calcium channels involved in bronchodilation. All these effects were directly related to the MOE content in honokiol and magnolol. In conclusion, the properties of MOE highlighted here strongly encourage its application as dietary supplement in the treatment of airway diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences and Biotechnology, School of Pharmacy and Heath Products, University of Ferrara, Ferrara, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences (DOCPAS), University of Ferrara, Ferrara, Italy.
- Department of Pharmacy and Biotechnology, Food Chemistry and Nutraceutical Lab, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
- Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
- Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
- UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy.
ORCID-Profile: Riccardo Fontana, Laura Beatrice Mattioli, Roberta Budriesi, Ivan Corazza, Peggy Marconi, Maria Frosini, Stefano Manfredini, Silvia Vertuani
Förderung
- University of Bologna
- University of Ferrara
- Università di Bologna
- Università degli Studi di Ferrara
Zitieren
APA
Fontana, R., Mattioli, L. B., Biotti, G., Budriesi, R., Gotti, R., Micucci, M., Corazza, I., Marconi, P., Frosini, M., Manfredini, S., Buzzi, R., & Vertuani, S. (2023). Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target. Phytotherapy Research. https://doi.org/10.1002/ptr.7786
Vancouver
Fontana R, Mattioli LB, Biotti G, Budriesi R, Gotti R, Micucci M, et al. Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target. Phytotherapy Research. 2023. doi:10.1002/ptr.7786
BibTeX
@article{Fontana2023,
author = {Fontana, Riccardo and Mattioli, Laura Beatrice and Biotti, Giulia and Budriesi, Roberta and Gotti, Roberto and Micucci, Matteo and Corazza, Ivan and Marconi, Peggy and Frosini, Maria and Manfredini, Stefano and Buzzi, Raissa and Vertuani, Silvia},
title = {Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7786}
}
EUVIMED